Logo - springer
Slogan - springer

| Molecular Diagnosis & Therapy – incl. option to publish open access (Editorial Board)

Molecular Diagnosis & Therapy

Molecular Diagnosis & Therapy

Editor: Alison Fitches

ISSN: 1177-1062 (print version)
ISSN: 1179-2000 (electronic version)

Journal no. 40291

E. Amir, Princess Margaret Cancer Centre, Toronto, ON, Canada

G. Bianchi, University Vita Salute San Raffaele, Milan, Italy

P.D. Burbelo, National Institutes of Health, Bethesda, MD, USA

C.R. Cantor, Boston University, Boston, MA, USA

D.L. Cooper, A City of Hope Cancer Center Laboratory, Phoenix, AZ, USA

W. De Spiegelaere, Ghent University, Ghent, Belgium

J. Desmeules, Hopitaux Universitaires de Geneve , Geneva, Switzerland

L.D. Dikkeschei, Isala Klinieken, Zwolle, the Netherlands

A.G. Frauman, University of Melbourne, Melbourne, VIC, Australia

R. Gambari, Ferrara University, Ferrara, Italy

G.S. Ginsburg, Duke University, Durham, NC, USA

S. Goodison, Mayo Clinic, Orlando, FL, USA

D. Gurwitz, Tel Aviv University, Tel Aviv, Israel

A. Hansen, Princess Margaret Cancer Centre, Toronto, ON, Canada

S. Huang, Helomics Corporation, Pittsburgh, PA, USA

M. Ingelman-Sundberg, Karolinska Institutet, Stockholm, Sweden

M.W. Jann, University of North Texas, Fort Worth, TX, USA

S.E. Langabeer, St. James's Hospital, Dublin, Ireland

S.B. Liggett, University of South Florida, Tampa, FL, USA

M.W. Linder, University of Louisville School of Medicine, Louisville, KY, USA

C. Lu, Harvard Medical School, Boston, MA, USA

J.J. McCarthy, Duke University Medical Center, Durham, NC, USA

U.A. Meyer, University of Basel, Basel, Switzerland

S. Peroutka, Semnur Pharmaceuticals, South San Francisco, CA, USA

M.J. Ratain, University of Chicago Medical Center, Chicago, IL, USA

P.M. Ridker, Brigham and Women's Hospital, Boston, MA, USA

W. Sadee, The Ohio State University, Columbus, OH, USA

M.M. Shi, Novartis Pharmaceuticals, East Hanover, NJ, USA

J. Simecka, UNT System College of Pharmacy, Fort Worth, TX, USA

K.D. Tew, Medical University of South Carolina, Charleston, SC, USA

J. Tost, Centre National de Recherche en Genomique Humaine, Evry, France

V. Van Deerlin, University of Pennsylvania, Philadelphia, PA, USA

D. Viswanatha, Mayo Clinic, Rochester, MN, USA

C.L. Vnencak-Jones, Vanderbilt University, Nashville, TN, USA

W.W. Weber, University of Michigan, Ann Arbor, MI, USA

R.L. Woosley, AZERT Inc, Oro Valley, AZ, USA

H.-G. Xie, General Clinical Research Center, Nanjing Medical University, Nanjing, China

 

Read this Journal on Springerlink

For authors and editors


  • Journal Citation Reports®
    2016 Impact Factor
  • 1.909
  • Aims and Scope

    Aims and Scope

    Close

    Molecular Diagnosis & Therapy welcomes current opinion articles on emerging or contentious issues, comprehensive narrative reviews, systematic reviews (as outlined by the PRISMA statement), original research articles (including short communications) and letters to the editor.  All manuscripts are subject to peer review by international experts.

    Topic coverage of the journal includes :

    • Use of biomarkers to guide drug development and to serve as diagnostics or prognostic tools
    • Detection, monitoring, and treatment of molecular causes of disease
    • Molecular markers and genetic variation affecting drug response, drug metabolism, adverse effects, and/or disease progression
    • Drug/diagnostic combinations (theranostics).
    • Emerging molecular diagnostic tools and technologies
    • Pathogen detection and drug resistance analysis
    • Ethical and regulatory issues relating to precision medicine

    Articles published in Molecular Diagnosis & Therapy may be accompanied by lay-level summaries, to assist patients, caregivers and others in understanding important medical advances.

  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for Authors

    Instructions for Authors

    Close

  • Important Information for Authors

    Important Information for Authors

    Close

  • Conflict of Interest form (doc, 84 kB)
  • Copyright Information

    Copyright Information

    Close

    Copyright Information

    For Authors

    Submission of a manuscript implies: that the work described has not been published before (except in form of an abstract or as part of a published lecture, review or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as – tacitly or explicitly – by the responsible authorities at the institution where the work was carried out.

    Author warrants (i) that he/she is the sole owner or has been authorized by any additional copyright owner to assign the right, (ii) that the article does not infringe any third party rights and no license from or payments to a third party is required to publish the article and (iii) that the article has not been previously published or licensed. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. Transfer of copyright to Springer (respective to owner if other than Springer) becomes effective if and when a Copyright Transfer Statement is signed or transferred electronically by the corresponding author. After submission of the Copyright Transfer Statement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted by Springer.

    The copyright to this article, including any graphic elements therein (e.g. illustrations, charts, moving images), is assigned for good and valuable consideration to Springer effective if and when the article is accepted for publication and to the extent assignable if assignability is restricted for by applicable law or regulations (e.g. for U.S. government or crown employees).

    The copyright assignment includes without limitation the exclusive, assignable and sublicensable right, unlimited in time and territory, to reproduce, publish, distribute, transmit, make available and store the article, including abstracts thereof, in all forms of media of expression now known or developed in the future, including pre- and reprints, translations, photographic reproductions and microform. Springer may use the article in whole or in part in electronic form, such as use in databases or data networks for display, print or download to stationary or portable devices. This includes interactive and multimedia use and the right to alter the article to the extent necessary for such use.

    Authors may self-archive the Author's accepted manuscript of their articles on their own websites. Authors may also deposit this version of the article in any repository, provided it is only made publicly available 12 months after official publication or later. He/she may not use the publisher's version (the final article), which is posted on SpringerLink and other Springer websites, for the purpose of self-archiving or deposit. Furthermore, the Author may only post his/her version provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com".

    Prior versions of the article published on non-commercial pre-print servers like arXiv.org can remain on these servers and/or can be updated with Author's accepted version. The final published version (in pdf or html/xml format) cannot be used for this purpose. Acknowledgement needs to be given to the final publication and a link must be inserted to the published article on Springer's website, accompanied by the text "The final publication is available at link.springer.com". Author retains the right to use his/her article for his/her further scientific career by including the final published journal article in other publications such as dissertations and postdoctoral qualifications provided acknowledgement is given to the original source of publication.

    Author is requested to use the appropriate DOI for the article. Articles disseminated via link.springer.com are indexed, abstracted and referenced by many abstracting and information services, bibliographic networks, subscription agencies, library networks, and consortia.

    For Readers

    While the advice and information in this journal is believed to be true and accurate at the date of its publication, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may have been made. The publisher makes no warranty, express or implied, with respect to the material contained herein.

    All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g., as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining written permission from the publisher (respective the copyright owner if other than Springer). The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

    Springer has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Springer content. For permission to reuse our content please locate the material that you wish to use on link.springer.com or on springerimages.com and click on the permissions link or go to copyright.com, then enter the title of the publication that you wish to use. For assistance in placing a permission request, Copyright Clearance Center can be connected directly via phone: +1-855-239-3415, fax: +1-978-646-8600, or e-mail: info@copyright.com.


    © Springer International Publishing Switzerland

Services for the Journal

Alerts for this journal

 

Get the table of contents of every new issue published in Molecular Diagnosis & Therapy.


Additional information